Estrogen-Independent Proliferation Is Present in Estrogen-Receptor<i>HER2</i>-Positive Primary Breast Cancer After Neoadjuvant Letrozole

Matthew J. Ellis, Yu Tao, Oliver Young, +11

Journal of Clinical Oncology

Letrozole Suppresses Plasma Estradiol and Estrone Sulphate More Completely Than Anastrozole in Postmenopausal Women With Breast Cancer

J. Michael Dixon, Lorna Renshaw, Oliver Young, +7

Journal of Clinical Oncology

Molecular response to aromatase inhibitor treatment in primary breast cancer

Alan Mackay, Ander Urruticoechea, J. Michael Dixon, +10

Breast Cancer Research

Increase in response rate by prolonged treatment with neoadjuvant letrozole

J. Michael Dixon, Lorna Renshaw, E. Jane Macaskill, +6

Breast Cancer Research and Treatment

OncologyMetronomic TherapyPharmacologyTreatment OptionResponse Rate +2

Cyclooxygenase-2 Inhibition Does Not Improve the Reduction in Ductal Carcinoma <i>In situ</i> Proliferation with Aromatase Inhibitor Therapy: Results of the ERISAC Randomized Placebo-Controlled Trial

Nigel Bundred, Angela Cramer, Julie Morris, +11

Clinical Cancer Research

Therapeutic mammaplasty is a safe and effective alternative to mastectomy with or without immediate breast reconstruction

Shelley Potter, Adam Trickey, Tim Rattay, +654

British journal of surgery

A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer

Fiona Mary McCaig, Lorna Renshaw, Linda Williams, +6

Breast Cancer Research and Treatment

Steroid MetabolismAromatase InhibitorsBreast OncologyOncologyMedicine +12

Patients’ Views of Treatment‐Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of <i>BRCA1</i> and <i>BRCA2</i> Testing

Sarah E. Wright, Mary Porteous, D. Stirling, +4

Journal of Genetic Counseling

Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability

J. Michael Dixon, Lorna Renshaw, C. Langridge, +8

Breast Cancer Research and Treatment

MedicineToxicologyPharmacology

Negotiating jurisdictional boundaries in response to new genetic possibilities in breast cancer care: The creation of an ‘oncogenetic taskscape’

Sarah E. Wright, Mary Porteous, D. Stirling, +3

Social Science & Medicine

NursingFamily MedicineGenetic TestingMedical EthicsBreast Oncology +9